LUSSO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 15.669
NA - Nord America 4.447
AS - Asia 1.680
SA - Sud America 225
AF - Africa 29
OC - Oceania 4
Totale 22.054
Nazione #
IT - Italia 14.660
US - Stati Uniti d'America 4.420
SG - Singapore 667
CN - Cina 641
UA - Ucraina 352
SE - Svezia 224
BR - Brasile 175
FI - Finlandia 123
VN - Vietnam 119
DE - Germania 98
GB - Regno Unito 89
FR - Francia 78
IN - India 60
HK - Hong Kong 42
KR - Corea 39
BD - Bangladesh 23
RU - Federazione Russa 22
TR - Turchia 17
AR - Argentina 16
IQ - Iraq 12
MX - Messico 11
CA - Canada 9
CO - Colombia 9
ID - Indonesia 9
EC - Ecuador 8
PH - Filippine 7
PK - Pakistan 7
UZ - Uzbekistan 7
NL - Olanda 6
PY - Paraguay 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
ES - Italia 4
KE - Kenya 4
MA - Marocco 4
MU - Mauritius 4
VE - Venezuela 4
AU - Australia 3
CL - Cile 3
ET - Etiopia 3
JP - Giappone 3
MY - Malesia 3
NP - Nepal 3
BO - Bolivia 2
DZ - Algeria 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
PL - Polonia 2
TN - Tunisia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 22.054
Città #
Cagliari 14.336
Woodbridge 537
Fairfield 534
Singapore 360
Houston 343
Ashburn 318
Chandler 315
Seattle 243
Ann Arbor 224
Cambridge 203
Wilmington 196
Boardman 193
Jacksonville 189
Dallas 157
Nyköping 153
Uta 143
Beijing 132
San Jose 132
Los Angeles 80
Hefei 76
Santa Clara 66
Helsinki 64
Boston 56
Buffalo 55
Nanjing 51
Lauterbourg 45
San Diego 43
Hong Kong 39
Seoul 36
Shanghai 34
Ho Chi Minh City 32
Milan 31
Verona 29
Pune 27
The Dalles 25
Nanchang 23
Hanoi 22
Hebei 22
Jiaxing 20
Changsha 18
Jinan 17
Shenyang 16
Munich 15
Tianjin 15
Sassari 14
Frankfurt am Main 12
New York 12
Guangzhou 11
London 10
São Paulo 10
Haiphong 9
Belo Horizonte 8
Norwalk 8
Nuremberg 7
Zhengzhou 7
Chicago 6
Council Bluffs 6
Delhi 6
Mountain View 6
Ningbo 6
Orange 6
Tashkent 6
Baghdad 5
Brooklyn 5
Can Tho 5
Dhaka 5
Saint Petersburg 5
Atlanta 4
Columbus 4
Goiânia 4
Redwood City 4
Salt Lake City 4
Taizhou 4
Washington 4
Asunción 3
Bangalore 3
Biên Hòa 3
Curitiba 3
Da Nang 3
Dearborn 3
Denver 3
Düsseldorf 3
Erbil 3
Hamburg 3
Hangzhou 3
Johannesburg 3
Kunming 3
Nairobi 3
Paris 3
Porto Alegre 3
Portsmouth 3
Rio de Janeiro 3
Rome 3
Salvador 3
San Francisco 3
Stockholm 3
Thái Bình 3
Tokyo 3
Tonara 3
Toronto 3
Totale 19.946
Nome #
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 1.686
Calibration Technologies for Correct Determination of Epstein-Barr Virus, Human Herpesvirus 6 (HHV-6), and HHV-8 Antiviral Drug Susceptibilities by Use of Real-Time-PCR-Based Assays 603
Chromosomally integrated human herpesvirus 6: questions and answers 577
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor 575
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity 569
Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections 564
Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of RANTES-Derived Peptides 559
Development of a Human Herpesvirus 6 Species-Specific Immunoblotting Assay 550
Classification of HHV-6A and HHV-6B as distinct viruses 541
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 539
Selective Reactivation of Human Herpesvirus 6 in Patients With Autoimmune Connective Tissue Diseases 533
Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples 510
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 496
Treatment with IL-7 Prevents the Decline of Circulating CD4(+) T Cells during the Acute Phase of SIV Infection in Rhesus Macaques 492
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis 481
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4(pos) T cells and macrophages 477
Protein-based HIV-1 microbicides. 475
Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability 474
lmmunomodulation and immunosuppression by human herpesvirus 6A and 6B 471
IL-7 induces expression and activation of integrin alpha 4 beta 7 promoting naive T-cell homing to the intestinal mucosa 420
Inhibition of HIV-1 Infection by Human alpha-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae 415
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 362
Human herpesvirus 6A accelerates AIDS progression in macaques 358
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT 346
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A 340
Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases 326
Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages 326
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein 324
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 322
Clinical significance of HIV-1 coreceptor usage 321
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2 317
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load 315
Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection 313
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 312
International network for comparison of HIV neutralization assays: the NeutNet report 311
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer 310
Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4 306
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 302
Identification of RANTES MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells 293
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains 281
HHV-6 and CMV pneumonitis in immunocompromised patients 280
Infection of natural killer cells by human herpesvirus 6 260
Selective suppression of IL-12 production by human herpesvirus 6 257
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 255
: Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 253
CD46 is a cellular receptor for human herpesvirus 6 252
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals 251
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection 247
HHV-6 and the immune system: mechanisms of immunomodulation and viral escape 246
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression 237
Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation 235
HIV and the chemokine system 231
A rationally designed CD4 mimic inhibits HIV-1 entry and exposes cryptic neutralization epitopes 218
Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 216
HIV and chemokines: Implications for therapy and vaccines 195
Structural determinants of HIV-1 blockade and CCR5 recognition in RANTES 188
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 187
Totale 22.100
Categoria #
all - tutte 44.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021318 0 0 0 0 0 0 0 0 0 126 122 70
2021/2022652 49 121 39 19 36 15 44 29 64 42 94 100
2022/20231.191 130 115 112 97 101 175 46 127 126 37 55 70
2023/20241.601 120 47 72 172 143 143 86 110 82 329 131 166
2024/20251.476 101 101 243 93 160 129 88 60 125 95 131 150
2025/20261.771 148 135 342 148 147 183 320 69 158 121 0 0
Totale 22.100